Market revenue in 2023 | USD 822.0 million |
Market revenue in 2030 | USD 1,151.4 million |
Growth rate | 4.9% (CAGR from 2023 to 2030) |
Largest segment | Ultrasound-based breast biopsy |
Fastest growing segment | Ultrasound-Based Breast Biopsy |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | MRI-Based Breast Biopsy, Ultrasound-Based Breast Biopsy, Mammography-Based (Stereotactic) Breast Biopsy, CT-Based Breast Biopsy, Other Technologies |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to breast cancer core needle biopsy market will help companies and investors design strategic landscapes.
Ultrasound-based breast biopsy was the largest segment with a revenue share of 34.53% in 2023. Horizon Databook has segmented the Global breast cancer core needle biopsy market based on mri-based breast biopsy, ultrasound-based breast biopsy, mammography-based (stereotactic) breast biopsy, ct-based breast biopsy, other technologies covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of global-level data and insights on the Global breast cancer core needle biopsy market , including forecasts for subscribers. This global databook contains high-level insights into Global breast cancer core needle biopsy market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account